All Stories

  1. Rose petal-derived nanovesicles as a sustainable and functional ingredient for next-generation cosmetics
  2. Cosmetics for Sensitive Skin: Assessing Rheological Properties, Stability, and Safety
  3. Microfluidic Design of Ultradeformable Liposomes for Advanced Skin Delivery of Stellaria media Phytocomplex
  4. Assessing effectiveness of multistage nanomedicines for multidrug therapy of vitiligo
  5. Chlorella-enriched hydrogels protect against myocardial damage and reactive oxygen species production in an in vitro ischemia/reperfusion model using cardiac spheroids
  6. Antimicrobial Compounds from Food Waste in Cosmetics
  7. OX26-cojugated gangliosilated liposomes to improve the post-ischemic therapeutic effect of CDP-choline
  8. Olive Leaves and Citrus Peels: From Waste to Potential Resource for Cosmetic Products
  9. Gelled Liquid Crystal Nanocarriers for Improved Antioxidant Activity of Resveratrol
  10. Solid Lipid Nanoparticles Containing Morin: Preparation, Characterization, and Ex Vivo Permeation Studies
  11. Bicalutamide Anticancer Activity Enhancement by Formulation of Soluble Inclusion Complexes with Cyclodextrins
  12. Chitosan/Cyclodextrin Nanospheres for Potential Nose-to-Brain Targeting of Idebenone
  13. In Situ Swelling Formulation of Glycerol-Monooleate-Derived Lyotropic Liquid Crystals Proposed for Local Vaginal Application
  14. A comparison between silicone‐free and silicone‐based emulsions: Technological features and in vivo evaluation
  15. Alginate-Based Composites for Corneal Regeneration: The Optimization of a Biomaterial to Overcome Its Limits
  16. Macrophage-Derived Extracellular Vesicles: A Promising Tool for Personalized Cancer Therapy
  17. Ammonium Glycyrrhizinate and Bergamot Essential Oil Co-Loaded Ultradeformable Nanocarriers: An Effective Natural Nanomedicine for In Vivo Anti-Inflammatory Topical Therapies
  18. Lyotropic Liquid Crystals: A Biocompatible and Safe Material for Local Cardiac Application
  19. Lipid-Based Formulations Containing Labrafil M2125-CS: A Deep Investigation on Nanosystem Stability
  20. Rutin-Loaded Nanovesicles for Improved Stability and Enhanced Topical Efficacy of Natural Compound
  21. Tendon Tissue Repair in Prospective of Drug Delivery, Regenerative Medicines, and Innovative Bioscaffolds
  22. Development of Chitosan/Cyclodextrin Nanospheres for Levofloxacin Ocular Delivery
  23. Positively Charged Lipid as Potential Tool to Influence the Fate of Ethosomes
  24. Radiopharmaceutical preparations: what are the legislative differences across Europe?
  25. Meglumine Antimoniate‐Loaded Aqueous‐Core PLA Nanocapsules: Old Drug, New Formulation against Leishmania ‐Related Diseases
  26. EtoGel for Intra-Articular Drug Delivery: A New Challenge for Joint Diseases Treatment
  27. Topical Unsaturated Fatty Acid Vesicles Improve Antioxidant Activity of Ammonium Glycyrrhizinate
  28. Nanonutraceuticals: The New Frontier of Supplementary Food
  29. Influence of Materials Properties on Bio-Physical Features and Effectiveness of 3D-Scaffolds for Periodontal Regeneration
  30. Rutin-Loaded Solid Lipid Nanoparticles: Characterization and In Vitro Evaluation
  31. Improvement of Ferulic Acid Antioxidant Activity by Multiple Emulsions: In Vitro and In Vivo Evaluation
  32. Oleuropein-Laded Ufasomes Improve the Nutraceutical Efficacy
  33. Targeting of the Pilosebaceous Follicle by Liquid Crystal Nanocarriers: In Vitro and In Vivo Effects of the Entrapped Minoxidil
  34. Design and Characterization of Glyceryl Monooleate-Nanostructures Containing Doxorubicin Hydrochloride
  35. Cardiac Stem Cell-Loaded Delivery Systems: A New Challenge for Myocardial Tissue Regeneration
  36. Vegetable-Milk-Based Yogurt-Like Structure: Rheological Properties Influenced by Gluten-Free Carob Seed Flour
  37. Ammonium glycyrrhizate skin delivery from ultradeformable liposomes: A novel use as an anti-inflammatory agent in topical drug delivery
  38. Influence of Various Model Compounds on the Rheological Properties of Zein-Based Gels
  39. Rutin-Loaded Poloxamer 407-Based Hydrogels for In Situ Administration: Stability Profiles and Rheological Properties
  40. The Rheolaser Master™ and Kinexus Rotational Rheometer® to Evaluate the Influence of Topical Drug Delivery Systems on Rheological Features of Topical Poloxamer Gel
  41. Poly(ethyl acrylate-co-methyl Methacrylate-co-trimethylammoniethyl methacrylate chloride) (Eudragit RS100) Nanocapsules as Nanovector Carriers for Phoenix dactylifera L. Seeds Oil: a Versatile Antidiabetic Agent
  42. Sulforaphane-Loaded Ultradeformable Vesicles as A Potential Natural Nanomedicine for the Treatment of Skin Cancer Diseases
  43. Development and In Vivo Evaluation of Multidrug Ultradeformable Vesicles for the Treatment of Skin Inflammation
  44. Physicochemical Characterization and Antioxidant Activity Evaluation of Idebenone/Hydroxypropyl-β-Cyclodextrin Inclusion Complex †
  45. Biogenic Amines, Phenolic, and Aroma-Related Compounds of Unroasted and Roasted Cocoa Beans with Different Origin
  46. Essential Oils-Loaded Polymer Particles: Preparation, Characterization and Antimicrobial Property
  47. Nanoformulation for potential topical delivery of Vismodegib in skin cancer treatment
  48. Polydocanol foam stabilized by liposomes: Supramolecular nanoconstructs for sclerotherapy
  49. Mathematical Models as Tools to Predict the Release Kinetic of Fluorescein from Lyotropic Colloidal Liquid Crystals
  50. Drug-Loaded Biocompatible Nanocarriers Embedded in Poloxamer 407 Hydrogels as Therapeutic Formulations
  51. Post-insertion parameters of PEG-derivatives in phosphocholine-liposomes
  52. Mathematical Models as Tools to Predict the Release Kinetic of Fluorescein from Monoglyceride Colloidal Liquid Crystals
  53. Mucosal Applications of Poloxamer 407-Based Hydrogels: An Overview
  54. Simultaneous quantification of Gemcitabine and Irinotecan hydrochloride in rat plasma by using high performance liquid chromatography-diode array detector
  55. An insight of in vitro transport of PEGylated non-ionic surfactant vesicles (NSVs) across the intestinal polarized enterocyte monolayers
  56. Sodium deoxycholate-decorated zein nanoparticles for a stable colloidal drug delivery system
  57. Innovative vesicles for dermal and transdermal drug delivery
  58. Characterization and in vitro anticancer properties of chitosan-microencapsulated flavan-3-ols-rich grape seed extracts
  59. Physicochemical characterization of pH-responsive and fusogenic self-assembled non-phospholipid vesicles for a potential multiple targeting therapy
  60. Interaction between PEG lipid and DSPE/DSPC phospholipids: An insight of PEGylation degree and kinetics of de-PEGylation
  61. Oleuropein Decreases Cyclooxygenase-2 and Interleukin-17 Expression and Attenuates Inflammatory Damage in Colonic Samples from Ulcerative Colitis Patients
  62. Anticancer activity of all- trans retinoic acid-loaded liposomes on human thyroid carcinoma cells
  63. pH-sensitive niosomes: Effects on cytotoxicity and on inflammation and pain in murine models
  64. Drug delivery in overcoming the blood–brain barrier: role of nasal mucosal grafting
  65. Improvement of Oral Bioavailability of Curcumin upon Microencapsulation with Methacrylic Copolymers
  66. Rutin-loaded chitosan microspheres: Characterization and evaluation of the anti-inflammatory activity
  67. Pharmacological effect of a new idebenone formulation in a model of carrageenan-induced inflammatory pain
  68. Microextraction by packed sorbent and HPLC–PDA quantification of multiple anti-inflammatory drugs and fluoroquinolones in human plasma and urine
  69. Preparation, characterization and photostability assessment of curcumin microencapsulated within methacrylic copolymers
  70. PDE5 Inhibitors-Loaded Nanovesicles: Physico-Chemical Properties and In Vitro Antiproliferative Activity
  71. Nanotherapeutics for anti-inflammatory delivery
  72. Cationic Supramolecular Vesicular Aggregates for Pulmonary Tissue Selective Delivery in Anticancer Therapy
  73. Niosomes as Drug Nanovectors: Multiscale pH-Dependent Structural Response
  74. Helicobacter pylori ATCC 43629/NCTC 11639 Outer Membrane Vesicles (OMVs) from Biofilm and Planktonic Phase Associated with Extracellular DNA (eDNA)
  75. Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma
  76. Influence of the Supramolecular Micro-Assembly of Multiple Emulsions on their Biopharmaceutical Features and In vivo Therapeutic Response
  77. HPLC–FLD and spectrofluorometer apparatus: How to best detect fluorescent probe-loaded niosomes in biological samples
  78. Determination of ciprofloxacin and levofloxacin in human sputum collected from cystic fibrosis patients using microextraction by packed sorbent-high performance liquid chromatography photodiode array detector
  79. Ultradeformable liposomes as multidrug carrier of resveratrol and 5-fluorouracil for their topical delivery
  80. Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy
  81. Bisphosphonate–polyaspartamide conjugates as bone targeted drug delivery systems
  82. Aqueous-core PEG-coated PLA nanocapsules for an efficient entrapment of water soluble anticancer drugs and a smart therapeutic response
  83. Polyaspartamide-Doxorubicin Conjugate as Potential Prodrug for Anticancer Therapy
  84. Targeting the thyroid gland with thyroid-stimulating hormone (TSH)-nanoliposomes
  85. Physicochemical features and transfection properties of chitosan/poloxamer 188/poly(D,L-lactide-co-glycolide) nanoplexes
  86. Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells
  87. A characterization study of resveratrol/sulfobutyl ether-β-cyclodextrin inclusion complex and in vitro anticancer activity
  88. Niosomes from 80s to present: The state of the art
  89. Ammonium glycyrrhizinate-loaded niosomes as a potential nanotherapeutic system for anti-inflammatory activity in murine models
  90. Anticancer activity of liposomal bergamot essential oil (BEO) on human neuroblastoma cells
  91. Liposomal chemotherapeutics
  92. Sustained Zero-Order Release of Intact Ultra-Stable Drug-Loaded Liposomes from an Implantable Nanochannel Delivery System
  93. Differential Scanning Calorimetry as a Tool to Investigate the Transfer of Anticancer Drugs to Biomembrane Model
  94. Gemcitabine-loaded biocompatible nanocapsules for the effective treatment of human cancer
  95. Interaction of pH-sensitive non-phospholipid liposomes with cellular mimetic membranes
  96. Anti-inflammatory activity of novel ammonium glycyrrhizinate/niosomes delivery system: Human and murine models
  97. Squalenoyl prodrug of paclitaxel: Synthesis and evaluation of its incorporation in phospholipid bilayers
  98. Folate-targeted supramolecular vesicular aggregates as a new frontier for effective anticancer treatment in in vivo model
  99. Improved in vitro and in vivo collagen biosynthesis by asiaticoside-loaded ultradeformable vesicles
  100. In vitro antimycoplasmal activity of citrus bergamia essential oil and its major components
  101. Low-Frequency Ultrasound in Medicine: An In Vivo Evaluation
  102. Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases
  103. Paclitaxel-loaded ethosomes®: Potential treatment of squamous cell carcinoma, a malignant transformation of actinic keratoses
  104. Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases
  105. Gemcitabine-loaded innovative nanocarriers vs GEMZAR: Biodistribution, pharmacokinetic features andin vivoantitumor activity
  106. Lipophilic Hydroxytyrosol Esters: Fatty Acid Conjugates for Potential Topical Administration
  107. Ethosomes® and transfersomes® containing linoleic acid: physicochemical and technological features of topical drug delivery carriers for the potential treatment of melasma disorders
  108. Gemcitabine-loaded chitosan microspheres. Characterization and biological in vitro evaluation
  109. Supramolecular devices to improve the treatment of brain diseases
  110. Liposomes as multicompartmental carriers for multidrug delivery in anticancer chemotherapy
  111. Drug Delivery Applications with Ethosomes
  112. Folate-targeted supramolecular vesicular aggregates based on polyaspartyl-hydrazide copolymers for the selective delivery of antitumoral drugs
  113. Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: Characterization and interaction with human lung fibroblasts
  114. In Vitro Evaluation of the Activity of Gemcitabine-Loaded Pegylated Unilamellar Liposomes Against Papillary Thyroid Cancer Cells~!2010-04-18~!2010-06-27~!2010-08-23~!
  115. Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR®: Biodistribution, pharmacokinetic features and in vivo antitumor activity
  116. Nanoparticulate devices for brain drug delivery
  117. A novel animal model to evaluate the ability of a drug delivery system to promote the passage through the BBB
  118. Turbiscan Lab® Expert analysis of the stability of ethosomes® and ultradeformable liposomes containing a bilayer fluidizing agent
  119. Novel PEG-coated niosomes based on bola-surfactant as drug carriers for 5-fluorouracil
  120. Retinoids: new use by innovative drug-delivery systems
  121. In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer
  122. Lipoamino Acid Prodrugs of Paclitaxel: Synthesis and Cytotoxicity Evaluation on Human Anaplastic Thyroid Carcinoma Cells
  123. Colloidal carriers for the enhanced delivery through the skin
  124. Liposomal delivery improves the growth-inhibitory and apoptotic activity of low doses of gemcitabine in multiple myeloma cancer cells
  125. Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer
  126. Improved In Vitro Anti-Tumoral Activity, Intracellular Uptake and Apoptotic Induction of Gemcitabine-Loaded Pegylated Unilamellar Liposomes
  127. In vitro skin permeation of sunscreen agents from O/W emulsions
  128. Innovative Drug Delivery Systems for the Administration of Natural Compounds
  129. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery
  130. Effects of Lipid Composition and Preparation Conditions on Physical-Chemical Properties, Technological Parameters and In Vitro Biological Activity of Gemcitabine-Loaded Liposomes
  131. In vitro antimycoplasmal activity of Melaleuca alternifolia essential oil
  132. Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin
  133. Electrocortical effects of MDMA are potentiated by acoustic stimulation in rats
  134. Physico-chemical characterization of disoxaril–dimethyl-β-cyclodextrin inclusion complex and in vitro permeation studies
  135. Combined NMR-crystallographic and modelling investigation of the inclusion of molsidomine into α-, β- and γ-cyclodextrins
  136. Ethosomes for skin delivery of ammonium glycyrrhizinate: In vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers
  137. Preparation of celecoxib-dimethyl-β-cyclodextrin inclusion complex: characterization and in vitro permeation study
  138. Tolerability and improved protective action of idebenone‐loaded pegylated liposomes on ethanol‐induced injury in primary cortical astrocytes**Preliminary data were presented at the Second International Conference on New Biomedical Materials, 5–8 April ...
  139. Combining NMR and molecular modelling in a drug delivery context: investigation of the multi-mode inclusion of a new NPY-5 antagonist bromobenzenesulfonamide into β-cyclodextrin
  140. Synthesis, Characterization and In Vitro Evaluation of Dimethyl-β-cyclodextrin-4-biphenylylacetic Acid Conjugate
  141. Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability
  142. Ethanol-induced injury in rat primary cortical astrocytes involves oxidative stress: effect of idebenone
  143. Preparation, characterization, molecular modeling and In vitro activity of paclitaxel–cyclodextrin complexes
  144. In vitro and in vivo evaluation of caffeic and ferulic acids as topical photoprotective agents